Rucaparib (IH) API: Advancing Oncology Solutions in API Manufacturing

Rucaparib (IH) has emerged as a significant innovation in the field of oncology, particularly in the treatment of ovarian and other solid tumors. Classified as a PARP (Poly ADP-Ribose Polymerase) inhibitor, it plays a critical role in targeting cance...